Find HYDROXYPROPYLMETHYLCELLULOSE manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Durapatite, 12167-74-7, Hydroxylapatite, Alveograf, Periograf, Calcium hydroxyapatite
Molecular Formula
Ca5HO13P3
Molecular Weight
502.3  g/mol
InChI Key
XYJRXVWERLGGKC-UHFFFAOYSA-D
FDA UNII
91D9GV0Z28

HYDROXYPROPYLMETHYLCELLULOSE
The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.
1 2D Structure

HYDROXYPROPYLMETHYLCELLULOSE

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
pentacalcium;hydroxide;triphosphate
2.1.2 InChI
InChI=1S/5Ca.3H3O4P.H2O/c;;;;;3*1-5(2,3)4;/h;;;;;3*(H3,1,2,3,4);1H2/q5*+2;;;;/p-10
2.1.3 InChI Key
XYJRXVWERLGGKC-UHFFFAOYSA-D
2.1.4 Canonical SMILES
[OH-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2]
2.2 Other Identifiers
2.2.1 UNII
91D9GV0Z28
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Alveograf

2. Calcitite

3. Calcium Hydroxyapatite

4. Durapatite

5. Hydroxyapatite, Calcium

6. Hydroxylapatite

7. Interpore 200

8. Interpore 500

9. Interpore-200

10. Interpore-500

11. Interpore200

12. Interpore500

13. Osprovit

14. Ossein Hydroxyapatite Compound

15. Ossein-hydroxyapatite Compound

16. Ossopan

17. Osteogen

18. Periograf

2.3.2 Depositor-Supplied Synonyms

1. Durapatite

2. 12167-74-7

3. Hydroxylapatite

4. Alveograf

5. Periograf

6. Calcium Hydroxyapatite

7. Radiesse

8. Tribasic Calcium Phosphate

9. Durapatite [usan]

10. Calcium Hydroxide Phosphate

11. Win 40350

12. Calcium Hydroxylapatite

13. Calcium Hydroxide Tris(phosphate)

14. Pentacalcium;hydroxide;triphosphate

15. Hydroxylapatite, Ceramic

16. Ossopan

17. Calcium Phosphate, Tribasic [nf]

18. 91d9gv0z28

19. Durapatite (usan)

20. Mfcd00010904

21. Win-40350

22. Apatite, Hydroxy

23. Supertite 10

24. Calcium Phosphate, Tribasic (nf)

25. Pentacalcium Hydroxide Triphosphate

26. Hydroxylapatite (ca5(oh)(po4)3)

27. Calcium Orthophosphate, Basic

28. Hsdb 5804

29. Dekacalcium-dihydrat-hexa(phosphat)

30. Calcium Tribasic Phosphate

31. Einecs 215-145-7

32. Pentacalcium Monohydroxyorthophosphate

33. Pentacalcium Hydroxide Tris(orthophosphate)

34. Unii-91d9gv0z28

35. Hydroxyl Apatite

36. Alveograf (tn)

37. Decacalcium Hexaphosphate Dihydroxide

38. Einecs 235-330-6

39. Durapatite [mi]

40. Microcrystalline Hydroxyapatite Concentrate

41. Hydroxyapatite Nanopowder

42. Hydroxyapatite Micronpowder

43. Hydroxylapatite, Fast Flow

44. Calcarea Phosphorica

45. Ec 235-330-6

46. Hydroxyapatite Nanoparticles

47. Durapatite [who-dd]

48. Calcium Hydroxide Phosphate (ca10(oh)2(po4)6)

49. Hydroxyapatite [inci]

50. Hydroxyapatite [mart.]

51. Chembl2218916

52. Calcium Phosphate,tribasic

53. Calcium Orthophosphates Nanopowder

54. Dtxsid50872537

55. Hydroxylapatite, (ca 35-40%)

56. Calcarea Phosphorica [hpus]

57. Calcium Phosphate [who-ip]

58. Calcium Phosphate (tribasic)

59. Calcium Hydroxyapatite [inci]

60. Hydroxyapatite Nanoparticles Dispersion

61. Calcii Phosphas [who-ip Latin]

62. Tribasic Calcium Phosphate [ii]

63. Calcium Phosphate,tribasic [vandf]

64. Db-041626

65. Tribasic Calcium Phosphate [usp-rs]

66. Tribasic Calcium Phosphate [who-ip]

67. Ft-0630391

68. D03303

69. D03922

70. Calcium Phosphate Tribasic 34 To 40% Calcium Basis

71. J-004582

72. J-005837

73. Q27271399

74. Hydroxyapatite Nanoparticles, 5-10% (w/v) Aqueous Colloidal Dispersion, 20-50nm Particles

75. Pentacalcium Hydroxide Tris(orthophosphate), With A Fluorine Content Of Less Than 0,005 % By Weight On The Dry Anhydrous Product

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 502.3 g/mol
Molecular Formula Ca5HO13P3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count13
Rotatable Bond Count0
Exact Mass501.675955 g/mol
Monoisotopic Mass501.675955 g/mol
Topological Polar Surface Area260 Ų
Heavy Atom Count21
Formal Charge0
Complexity36.8
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count9
4 Drug and Medication Information
4.1 Therapeutic Uses

EXPT USE: WOMEN WITH PRIMARY BILIARY CIRRHOSIS MALABSORB CALCIUM, PHOSPHATE & VITAMIN D, & DEVELOP ACCELERATED CORTICAL BONE THINNING. HYDROXYAPATITE WAS ASSESSED FOR ITS VALUE IN THE TREATMENT OF CORTICAL BONE THINNING IN PRIMARY BILIARY CIRRHOSIS. CORTICAL BONE LOSS OCCURRED IN THE CONTROL GROUP. THE HYDROXYAPATITE GROUP SHOWED A SIGNIFICANT GAIN IN CORTICAL BONE THICKNESS.

PMID:6287835 EPSTEIN O ET AL; AM J CLIN NUTR 36 (3): 426 (1982)


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Biocompatible Materials

Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. (See all compounds classified as Biocompatible Materials.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Blood Coagulation Factor [EPC]

API SUPPLIERS

read-more
read-more

01

HOYA CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

HOYA CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

HOYA CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

HOYA CORP

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Country

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Toagosei

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

Toagosei

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Hercules Pharmaceuticals

Netherlands

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

Hercules Pharmaceuticals

Netherlands

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Bio-Rad Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

Bio-Rad Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Pierre Fabre

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

Pierre Fabre

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF CEP/COS Inactive-api JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Pierre Fabre

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DDL Conference
Not Confirmed
arrow

Pierre Fabre

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
DDL Conference
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty